InterCure Ltd.
INCR
$5.25
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 78.55M | 72.28M | 66.69M | 65.37M | 64.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 78.55M | 72.28M | 66.69M | 65.37M | 64.56M |
| Cost of Revenue | 67.22M | 60.97M | 55.40M | 54.12M | 53.18M |
| Gross Profit | 11.33M | 11.31M | 11.29M | 11.25M | 11.38M |
| SG&A Expenses | 27.98M | 28.19M | 28.67M | 29.13M | 29.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.72M | 5.52M | 7.41M | 6.34M | 5.21M |
| Total Operating Expenses | 99.03M | 94.79M | 91.59M | 89.70M | 88.28M |
| Operating Income | -20.48M | -22.51M | -24.90M | -24.33M | -23.72M |
| Income Before Tax | -13.28M | -18.85M | -24.61M | -24.09M | -23.57M |
| Income Tax Expenses | -2.20M | -3.31M | -4.46M | -4.19M | -3.92M |
| Earnings from Continuing Operations | -11.08 | -15.54 | -20.15 | -19.90 | -19.65 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 322.20K | 654.50K | 990.90K | 1.17M | 1.35M |
| Net Income | -10.76M | -14.88M | -19.16M | -18.73M | -18.30M |
| EBIT | -20.48M | -22.51M | -24.90M | -24.33M | -23.72M |
| EBITDA | -17.09M | -19.20M | -21.65M | -21.41M | -21.11M |
| EPS Basic | -1.06 | -1.60 | -2.17 | -2.13 | -2.08 |
| Normalized Basic EPS | -1.52 | -1.76 | -2.02 | -1.97 | -1.92 |
| EPS Diluted | -1.06 | -1.61 | -2.17 | -2.13 | -2.09 |
| Normalized Diluted EPS | -1.52 | -1.76 | -2.02 | -1.97 | -1.92 |
| Average Basic Shares Outstanding | 42.99M | 41.65M | 40.31M | 38.50M | 36.70M |
| Average Diluted Shares Outstanding | 42.99M | 41.65M | 40.31M | 38.50M | 36.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |